439 related articles for article (PubMed ID: 11002217)
1. Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases.
Kusunoki M; Yanagi H; Noda M; Yoshikawa R; Yamamura T
Cancer; 2000 Sep; 89(6):1228-35. PubMed ID: 11002217
[TBL] [Abstract][Full Text] [Related]
2. [5-FU pharmacokinetic study of 5-FU hepato-arterial infusion with oral UFT].
Maruyama M; Ebuchi M; Nagahama T; Takashima I; Hasegawa K; Ochiai T; Natui S
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2109-11. PubMed ID: 12484014
[TBL] [Abstract][Full Text] [Related]
3. [The 5-fluorouracil hepato-arterial infusion with oral UFT therapy for the hepatic and extra hepatic metastases of colorectal cancer].
Maruyama S; Maruyama M; Kato K; Koide A; Ohbu M; Hasegawa K; Takashima I; Ebuchi M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1743-5. PubMed ID: 15553701
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
5. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
6. [A case report--combination chemotherapy with oral UFT and CPT-11, 5-FU, l-LV by hepatic arterial infusion for multiple hepatic metastasis from sigmoid colon cancer].
Kubo H; Kanekiyo S; Watanabe Y; Tada K; Hasegawa H
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2313-6. PubMed ID: 18079638
[TBL] [Abstract][Full Text] [Related]
7. A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundation for Multidisciplinary Treatment of Cancer 32).
Kusano M; Aoyama T; Okabayashi K; Hirata K; Tsuji Y; Nakamori S; Asahara T; Ohashi Y; Yoshikawa T; Sakamoto J; Oba K; Saji S
J Cancer Res Ther; 2018 Sep; 14(Supplement):S761-S766. PubMed ID: 30249900
[TBL] [Abstract][Full Text] [Related]
8. [Long survival in a case of unresectable hepatic metastasis from rectal carcinoma treated with second-look hepatectomy plus pharmacokinetic modulating chemotherapy (PMC)].
Noda M; Kusunoki M; Yanagi H; Yoshikawa R; Yamamura T
Gan To Kagaku Ryoho; 2001 Jan; 28(1):99-103. PubMed ID: 11201390
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastases.
Yamaguchi T; Matsumoto H; Yasutome M; Mori T; Takahashi K
Cancer Chemother Pharmacol; 2011 Mar; 67(3):629-35. PubMed ID: 20495917
[TBL] [Abstract][Full Text] [Related]
10. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
[TBL] [Abstract][Full Text] [Related]
11. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
Ishida H; Yamada H; Shirakawa K; Nakada H; Ohsawa T; Takeuchi I; Okada N; Yokoyama M; Inokuma S; Suzuki T; Odaka A; Hoshino T; Murata N; Hashimoto D; Itoyama S; Mori T; Matsumoto Y; Miura T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1621-6. PubMed ID: 14619479
[TBL] [Abstract][Full Text] [Related]
12. [A case of liver and lung metastases of rectal cancer responding well to 5-FU hepato-arterial infusion (HAI) with combined use of oral UFT].
Hasegawa K; Maruyama M; Nagahama T; Takashima I; Shinoura H; Kato K; Ebuchi M
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1678-81. PubMed ID: 14619492
[TBL] [Abstract][Full Text] [Related]
13. [Hepatic arterial infusion (HAI) chemotherapy achieved a complete response (CR) for multiple liver metastases of colorectal cancer--two case reports].
Ishibashi K; Yoshimatsu K; Yokomizo H; Umehara A; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1832-4. PubMed ID: 16315955
[TBL] [Abstract][Full Text] [Related]
14. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study.
Tono T; Hasuike Y; Ohzato H; Takatsuka Y; Kikkawa N
Cancer; 2000 Apr; 88(7):1549-56. PubMed ID: 10738212
[TBL] [Abstract][Full Text] [Related]
15. [Two case reports of complete regression of liver metastases from colorectal cancer after locoregional immunochemotherapy].
Ueda Y; Naito K; Iwamoto A; Tagi T; Shimizu K; Shiozaki A; Tamai H; Ochiai T; Sonoyama T; Yamagishi H
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1671-3. PubMed ID: 15553679
[TBL] [Abstract][Full Text] [Related]
16. [Combined chemotherapy with oral leucovorin (LV) + tegafur/uracil (UFT) and hepatic arterial infusion (HAI) therapy for liver metastasis of colorectal cancer].
Hasegawa S; Matsumoto S; Kawashima K; Fujii H; Hatano E; Satoh S; Ikai I; Shimahara Y
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1045-9. PubMed ID: 16044971
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic modulating chemotherapy highly effective for colorectal carcinoma metastases to multiple organs].
Muneoka K; Shirai Y; Wakai T; Yokoyama N; Okumura S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Jun; 32(6):799-802. PubMed ID: 15984519
[TBL] [Abstract][Full Text] [Related]
18. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
[TBL] [Abstract][Full Text] [Related]
19. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV
J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
